Advances in Urology / 2009 / Article / Tab 3 / Review Article
Brachytherapy for Prostate Cancer: A Systematic Review Table 3 LDR brachytherapy: clinical results for patients with high-risk prostate cancer treated with combined brachytherapy and androgen deprivation or external-beam radiation therapy.
Author Number of patients PSA relapse definition Median followup Years after diagnosis % of biochimical free reccurence Ellis et al. [21 ] 239 ASTRO 47 MONTHS 7 72.5 Dattoli et al. [44 ] 243
0.2 ng/mL8.5 YEARS 13 81 Merrick et al. [45 ] 204
0.4 ng/mL7 YEARS 10 86.6 Zelefsky et al. [22 ] 192 ASTRO 63 MONTHS 8 48 Khaksar et al. [25 ] 43 ASTRO 45 MONTHS 5 93 Guedea et al. [26 ] 30 ASTRO 30 MONTHS 3 81 Stock et al. [14 ] 360 ASTRO 4.2 YEARS 7 83 Copp et al. [46 ] 93 ASTRO 54 MONTHS 4 77 Potters et al. [28 ] 418 ASTRO 82 MONTHS 12 63 Sharkey et al. [29 ] 1707 ASTRO — 12 88 Joseph et al. [30 ] 667 ASTRO 31 MONTHS 8 52.6 Critz and Levinson [31 ] 1469
0.2 ng/mL6 YEARS 10 61 Battermann et al. [33 ] 114 ASTRO 48 MONTHS 5 54 Sylvester et al. [35 ] 77 2 PSA rises 63 MONTHS 10 47 Koutrouvelis et al. [41 ] 280 ASTRO 4 .5 YEARS 5 81 Kwok et al. [36 ] 28 ASTRO 7 YEARS 5 24